Loading company…
NX Prenatal develops blood testing for maternal and fetal health, aimed at preventing pregnancy complications.
Founded by Brian Brohman and headquartered in Louisville, US, NX Prenatal Inc. offers first-trimester blood testing that can be performed as early as 9-13 weeks of pregnancy to assess risk for complications such as preterm birth and preeclampsia. Its services are aimed at expectant mothers, obstetricians and healthcare providers, and are billed per test. In March 2020 the company raised USD 5.00 mn in Series A funding from Solas BioVentures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in